Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The pharmaceutical giant, best known for its COVID-19 products (Paxlovid and ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Freedman said that the rate cut depends on the Fed’s path, therefore an accurate prediction ... Overall, PFE ranks 6th on our ...

Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...

So far, investors haven't noticed. The stock trades near its lowest price in over a decade, and the dividend yield (6.7% as of this writing) hasn't been this high since the financial crisis in ...